MAXCYTE INC. - COMMON STOCK

MaxCyte to Report First Quarter 2022 Financial Results on May 9, 2022

20 أبريل 2022 16:05:00 بحسب Nasdaq GlobeNewswire

MaxCyte Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

15 أبريل 2022 09:00:00 بحسب Nasdaq GlobeNewswire

MaxCyte Announces Departure of CFO and Appointment of Ron Holtz as Interim CFO, Announces Preliminary First Quarter 2022 Revenue

12 أبريل 2022 16:05:00 بحسب Nasdaq GlobeNewswire

MaxCyte Reports Fourth Quarter and Full Year Financial Results

22 مارس 2022 16:05:01 بحسب Nasdaq GlobeNewswire

MaxCyte, Inc. Names Cenk Sumen Chief Scientific Officer

09 مارس 2022 16:15:00 بحسب Nasdaq GlobeNewswire

MaxCyte to Report Fourth Quarter and Full Year 2021 Financial Results on March 22, 2022

24 فبراير 2022 08:00:01 بحسب Nasdaq GlobeNewswire

MaxCyte to Participate in Upcoming Investor Conferences

14 فبراير 2022 08:00:01 بحسب Nasdaq GlobeNewswire

MaxCyte Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

11 فبراير 2022 17:00:00 بحسب Nasdaq GlobeNewswire

MaxCyte Signs Strategic Platform License with Intima Bioscience to Advance Tumor Infiltrating Lymphocytes Programs

01 فبراير 2022 02:00:00 بحسب Nasdaq GlobeNewswire

MaxCyte Announces Strong Preliminary Unaudited Fourth Quarter and Full Year 2021 Revenue Results

24 يناير 2022 02:30:00 بحسب Nasdaq GlobeNewswire

MaxCyte to Participate in Upcoming Investor Conferences

12 نوفمبر 2021 08:00:01 بحسب Nasdaq GlobeNewswire

MaxCyte Reports Third Quarter Financial Results

10 نوفمبر 2021 16:00:00 بحسب Nasdaq GlobeNewswire

MaxCyte Board Member Richard Douglas, PhD, Appointed Chairman of the Board

03 نوفمبر 2021 09:00:02 بحسب Nasdaq GlobeNewswire

Result of AGM

29 أكتوبر 2021 12:40:00 بحسب Nasdaq GlobeNewswire

MaxCyte Signs Strategic Platform License with Nkarta, Inc. to Advance Natural Killer Cell Therapy Programs

28 أكتوبر 2021 10:00:00 بحسب Nasdaq GlobeNewswire

MaxCyte to Report Third Quarter 2021 Financial Results on November 10, 2021

25 أكتوبر 2021 16:30:00 بحسب Nasdaq GlobeNewswire

MaxCyte Set to Join Russell 2000® Index

17 سبتمبر 2021 08:35:00 بحسب Nasdaq GlobeNewswire

MaxCyte Reports Second Quarter and Half-Year 2021 Financial Results Provides Preliminary 2021 Revenue Projections

13 سبتمبر 2021 16:05:00 بحسب Nasdaq GlobeNewswire

MaxCyte to Report Second Quarter 2021 Financial Results on September 13, 2021

02 سبتمبر 2021 08:05:00 بحسب Nasdaq GlobeNewswire